NovoCure (NVCR) Gross Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 249.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.00 |
| Dec 31, 2025 | -343.00 |
| Sep 30, 2025 | -394.00 |
| Jun 30, 2025 | -307.00 |
| Mar 31, 2025 | -53.00 |
| Dec 31, 2024 | 358.00 |
| Sep 30, 2024 | 240.00 |
| Jun 30, 2024 | 394.00 |
| Mar 31, 2024 | -9.00 |
| Dec 31, 2023 | -184.00 |
| Sep 30, 2023 | -250.00 |
| Jun 30, 2023 | -675.00 |
| Mar 31, 2023 | -408.00 |
| Dec 31, 2022 | -21.00 |
| Sep 30, 2022 | -10.00 |
| Jun 30, 2022 | 119.00 |
| Mar 31, 2022 | -57.00 |
| Dec 31, 2021 | -274.00 |
| Sep 30, 2021 | -120.00 |
| Jun 30, 2021 | 55.00 |
| Mar 31, 2021 | 447.00 |
| Dec 31, 2020 | 543.00 |
| Sep 30, 2020 | 347.00 |
| Jun 30, 2020 | 237.00 |
| Mar 31, 2020 | 297.00 |
| Dec 31, 2019 | 807.00 |
| Sep 30, 2019 | 439.00 |
| Jun 30, 2019 | 790.00 |
| Mar 31, 2019 | 796.00 |
| Dec 31, 2018 | -391.00 |
| Sep 30, 2018 | 98.00 |
| Jun 30, 2018 | 203.00 |
| Mar 31, 2018 | -155.00 |
| Dec 31, 2017 | 714.00 |
| Sep 30, 2017 | 2,106.00 |
| Jun 30, 2017 | 5,619.00 |
| Mar 31, 2017 | 2,771.00 |
| Dec 31, 2016 | 1,462.00 |
| Sep 30, 2016 | 1,191.00 |
| Jun 30, 2016 | -1,786.00 |
| Mar 31, 2016 | 1,368.00 |
| Dec 31, 2015 | 1,828.00 |
| Sep 30, 2015 | -409.00 |